Drug Profile
Research programme: biodefence DNA vaccines - Ichor Medical Systems/USAMRIID
Alternative Names: Biodefense DNA vaccines - Ichor Medical Systems/USAMRIID; DNA vaccines - Ichor; Electroporation-mediated DNA vaccines - Ichor/US Army; EP-mediated DNA vaccines - Ichor; EP-mediated pDNA vaccines - Ichor; Plasmid DNA vaccines - IchorLatest Information Update: 02 Apr 2018
Price :
$50
*
At a glance
- Originator Ichor Medical Systems; United States Army Medical Research Institute of Infectious Diseases
- Class Bacterial vaccines; DNA vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Eastern equine encephalomyelitis; Venezuelan equine encephalomyelitis; Western equine encephalitis virus infections
- Discontinued Anthrax
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Eastern equine encephalomyelitis (Prevention) in USA (IM, Injection)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Eastern equine encephalomyelitis (Prevention) in USA (Intradermal, Injection)
- 30 Dec 2013 Discontinued - Preclinical for Anthrax in USA (IM)